These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 28842195)

  • 1. Effects of a combination of 3,4-methylenedioxymeth amphetamine and caffeine on real time stimulated dopamine release in the rat striatum: Studies using fast cyclic voltammetry.
    O'Connor JJ; O'Boyle KM; Lowry JP
    J Neurosci Methods; 2018 Apr; 300():216-223. PubMed ID: 28842195
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A role for adenosine A(1) receptor blockade in the ability of caffeine to promote MDMA "Ecstasy"-induced striatal dopamine release.
    Vanattou-Saïfoudine N; Gossen A; Harkin A;
    Eur J Pharmacol; 2011 Jan; 650(1):220-8. PubMed ID: 20951694
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacodynamic interactions between MDMA and concomitants in MDMA tablets on extracellular dopamine and serotonin in the rat brain.
    Ikeda R; Igari Y; Fuchigami Y; Wada M; Kuroda N; Nakashima K
    Eur J Pharmacol; 2011 Jun; 660(2-3):318-25. PubMed ID: 21497593
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Studies on striatal neurotoxicity caused by the 3,4-methylenedioxymethamphetamine/ malonate combination: implications for serotonin/dopamine interactions.
    Goñi-Allo B; Ramos M; Herv'as I; Lasheras B; Aguirre N
    J Psychopharmacol; 2006 Mar; 20(2):245-56. PubMed ID: 16510482
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Direct effects of 3,4-methylenedioxymethamphetamine (MDMA) on serotonin or dopamine release and uptake in the caudate putamen, nucleus accumbens, substantia nigra pars reticulata, and the dorsal raphé nucleus slices.
    Iravani MM; Asari D; Patel J; Wieczorek WJ; Kruk ZL
    Synapse; 2000 Jun; 36(4):275-85. PubMed ID: 10819905
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protein kinase C inhibition differentially affects 3,4-methylenedioxymethamphetamine-induced dopamine release in the striatum and prefrontal cortex of the rat.
    Nair SG; Gudelsky GA
    Brain Res; 2004 Jul; 1013(2):168-73. PubMed ID: 15193525
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 3,4-Methylenedioxymethamphetamine (MDMA) Alters Synaptic Dopamine Release in the Dorsal Striatum Through Nicotinic Receptors and DAT Inhibition.
    Rizzo FR; Federici M; Mercuri NB
    Neuroscience; 2018 May; 377():69-76. PubMed ID: 29510210
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of ethanol and 3,4-methylenedioxymethamphetamine (MDMA) alone or in combination on spontaneous and evoked overflow of dopamine, serotonin and acetylcholine in striatal slices of the rat brain.
    Riegert C; Wedekind F; Hamida SB; Rutz S; Rothmaier AK; Jones BC; Cassel JC; Jackisch R
    Int J Neuropsychopharmacol; 2008 Sep; 11(6):743-63. PubMed ID: 18248690
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Studies, using in vivo microdialysis, on the effect of the dopamine uptake inhibitor GBR 12909 on 3,4-methylenedioxymethamphetamine ('ecstasy')-induced dopamine release and free radical formation in the mouse striatum.
    Camarero J; Sanchez V; O'Shea E; Green AR; Colado MI
    J Neurochem; 2002 Jun; 81(5):961-72. PubMed ID: 12065608
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dopamine D1 receptor-mediated intracellular responses in the hypothalamus after co-administration of caffeine with MDMA.
    Vanattou-Saïfoudine N; Behan B; Harkin A
    Basic Clin Pharmacol Toxicol; 2012 Mar; 110(3):283-9. PubMed ID: 21967278
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypothyroidism alters striatal dopamine release mediated by 3,4-methylenedioxymethamphetamine (MDMA, ecstasy).
    Peterson AL; Gilman TL; Banks ML; Sprague JE
    Synapse; 2006 Apr; 59(5):317-9. PubMed ID: 16421905
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elevation of ambient room temperature has differential effects on MDMA-induced 5-HT and dopamine release in striatum and nucleus accumbens of rats.
    O'Shea E; Escobedo I; Orio L; Sanchez V; Navarro M; Green AR; Colado MI
    Neuropsychopharmacology; 2005 Jul; 30(7):1312-23. PubMed ID: 15688085
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute effects of 3,4-methylenedioxymethamphetamine on striatal single-unit activity and behavior in freely moving rats: differential involvement of dopamine D(1) and D(2) receptors.
    Ball KT; Budreau D; Rebec GV
    Brain Res; 2003 Dec; 994(2):203-15. PubMed ID: 14642646
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulation of methylenedioxymethamphetamine-induced striatal dopamine release by the interaction between serotonin and gamma-aminobutyric acid in the substantia nigra.
    Yamamoto BK; Nash JF; Gudelsky GA
    J Pharmacol Exp Ther; 1995 Jun; 273(3):1063-70. PubMed ID: 7791076
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MDMA ('ecstasy') enhances basal acetylcholine release in brain slices of the rat striatum.
    Fischer HS; Zernig G; Schatz DS; Humpel C; Saria A
    Eur J Neurosci; 2000 Apr; 12(4):1385-90. PubMed ID: 10762366
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of dopamine release by methylenedioxymethamphetamine is mediated by serotonin.
    Gazzara RA; Takeda H; Cho AK; Howard SG
    Eur J Pharmacol; 1989 Sep; 168(2):209-17. PubMed ID: 2575036
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blockade of striatal 5-hydroxytryptamine2 receptors reduces the increase in extracellular concentrations of dopamine produced by the amphetamine analogue 3,4-methylenedioxymethamphetamine.
    Schmidt CJ; Sullivan CK; Fadayel GM
    J Neurochem; 1994 Apr; 62(4):1382-9. PubMed ID: 7907650
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potentiation of 3,4-methylenedioxymethamphetamine-induced dopamine release and serotonin neurotoxicity by 5-HT2 receptor agonists.
    Gudelsky GA; Yamamoto BK; Nash JF
    Eur J Pharmacol; 1994 Nov; 264(3):325-30. PubMed ID: 7698172
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A study of the mechanisms involved in the neurotoxic action of 3,4-methylenedioxymethamphetamine (MDMA, 'ecstasy') on dopamine neurones in mouse brain.
    Colado MI; Camarero J; Mechan AO; Sanchez V; Esteban B; Elliott JM; Green AR
    Br J Pharmacol; 2001 Dec; 134(8):1711-23. PubMed ID: 11739248
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of adenosine A1 and A2A receptors in the caffeine effect on MDMA-induced DA and 5-HT release in the mouse striatum.
    Górska AM; Gołembiowska K
    Neurotox Res; 2015 Apr; 27(3):229-45. PubMed ID: 25391902
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.